NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Corline Biomedical AB (ST: CLBIO)
CLBIO Technical Analysis
4
As on 28th Apr 2025 CLBIO STOCK Price closed @ 10.75 and we RECOMMEND Sell for LONG-TERM with Stoploss of 12.06 & Strong Sell for SHORT-TERM with Stoploss of 13.78 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CLBIOSTOCK Price
Open | 9.82 | Change | Price | % |
High | 11.30 | 1 Day | 1.45 | 15.59 |
Low | 9.70 | 1 Week | 1.27 | 13.40 |
Close | 10.75 | 1 Month | 1.35 | 14.36 |
Volume | 46693 | 1 Year | -3.20 | -22.94 |
52 Week High 15.75 | 52 Week Low 6.14 |
ST Sweden Most Active Stocks
FING-B | 0.02 | 0.00% |
HDW-B | 0.00 | % |
ENERS | 0.00 | % |
SCOL | 0.01 | 0.00% |
WYLD | 0.05 | 0.00% |
LUNE | 21.97 | 6.65% |
QUIA | 0.01 | 0.00% |
SBB-B | 3.84 | -1.79% |
POLY | 0.04 | 0.00% |
QLINEA | 0.04 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
CLBIO Daily Charts |
CLBIO Intraday Charts |
Whats New @ Bazaartrend |
CLBIO Free Analysis |
|
CLBIO Important Levels Intraday
RESISTANCE | 13.83 |
RESISTANCE | 12.84 |
RESISTANCE | 12.23 |
RESISTANCE | 11.62 |
SUPPORT | 9.88 |
SUPPORT | 9.27 |
SUPPORT | 8.66 |
SUPPORT | 7.67 |
CLBIO Forecast April 2025
4th UP Forecast | 17.98 |
3rd UP Forecast | 15.66 |
2nd UP Forecast | 14.23 |
1st UP Forecast | 12.79 |
1st DOWN Forecast | 8.71 |
2nd DOWN Forecast | 7.27 |
3rd DOWN Forecast | 5.84 |
4th DOWN Forecast | 3.52 |
CLBIO Weekly Forecast
4th UP Forecast | 15.28 |
3rd UP Forecast | 13.83 |
2nd UP Forecast | 12.93 |
1st UP Forecast | 12.03 |
1st DOWN Forecast | 9.47 |
2nd DOWN Forecast | 8.57 |
3rd DOWN Forecast | 7.67 |
4th DOWN Forecast | 6.22 |
CLBIO Forecast2025
4th UP Forecast | 31.6 |
3rd UP Forecast | 24.91 |
2nd UP Forecast | 20.78 |
1st UP Forecast | 16.65 |
1st DOWN Forecast | 4.85 |
2nd DOWN Forecast | 0.72 |
3rd DOWN Forecast | -3.41 |
4th DOWN Forecast | -10.1 |
Corline Biomedical AB ( ST Sweden Symbol : CLBIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CLBIO Other Details
Segment | EQ | |
Market Capital | 321287456.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
CLBIO Address
![]() |
CLBIO Latest News
CLBIO Business Profile
Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; CHC, which is used for the treatment of soft tissue injuries; medical devices; and CHS, a coronary stent. The company was founded in 1991 and is based in Uppsala, Sweden. Address: Lefflersgatan 5, Uppsala, Sweden, 754 50
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service